Episode 128 - Finerenone with SGLT2 inhibitors for CKD and Type 2 Diabetes

<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1743909/open_sms">Send us a text</a></p><p>Welcome back Rounds Table Listeners! Today we have a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the simultaneous initiation of SGLT2 inhibitors and finerenone (a nonsteroidal mineralocorticoid receptor antagonist) in persons with chronic kidney disease and type 2 diabetes. Here we go!</p><ol><li><a href='https://www.nejm.org/doi/full/10.1056/NEJMoa2410659'>Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes</a> (0:00 – 9:28).</li></ol><p>Calling keen trainees! (9:29 - 10:28)</p><ul><li>Trainees, med students, residents: <em>The Rounds Table</em> and <em>Trial Files</em> are looking for keen individuals to support our efforts.</li><li><em>Trial Files</em> is a free monthly newsletter on practice-changing trials, delivered straight to your inbox (<a href='https://trialfiles.substack.com/'>https...